Lv, Haijin
Chen, Wenjie
Xiang, Andy Peng
Zhang, Qi
Yang, Yang
Yi, Huimin http://orcid.org/0000-0001-5590-8874
Lv, Haijin
Yi, Huimin
Yi, Xiaomeng
An, Yuling
Wei, Xuxia
Lu, Pinglan
Fan, Mingming
Gong, Xunan
Liu, Jianrong
Guo, Jun
Zhou, Mi
Liu, Jianrong
Yang, Yang
Han, Fei
Chen, Guihua
Wang, Yanhong
Shi, Yunfeng
Wu, Benquan
Xian, Ying
Bi, Xiaogang
Zhang, Kouxing
Zhang, Qi
Chen, Wenjie
Lu, Jianxi
Liu, Chang
Guo, Yuefei
,
Funding for this research was provided by:
The Third Affiliated Hospital of Sun Yat-Sen University, Clinical Research Program (QHJH201804)
National Major Science and Technology Projects of China (2018ZX10723203)
National Key Research and Development Program of China Stem Cell and Translational Research (2017YFA0104304)
National Natural Science Foundation of China (81770651)
Science and Technology Planning Project of Guangdong Province of China (2019B020236003)
Guangdong Natural Science Foundation (2018A0303130305)
Article History
Accepted: 18 May 2020
First Online: 8 June 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The study was approved in 2017 [Approval No. 2017-22] and revised in 2019 [Approval No. 2019-19] by the Stem Cells Specific Ethics Committee of the Third affiliated hospital of Sun Yat-sen University and registered with ClinicalTrials.gov, number NCT03608592.
: Informed consent was obtained from all individual participants included in the study.